ALSO NOTED: FDA rejects Questcor application; Agency wants more Merck data; Cell Therapeutics sub names officers; NICE rejects

> Questcor Pharmaceuticals says the FDA has issued a "not approvable" letter for H.P. Acthar Gel (repository corticotropin injection) for the treatment of infantile spasms. Release

> Merck says that the FDA has asked for more data on Emend, an intravenous version of a drug designed to relieve nausea in chemo patients. An oral version has already been approved and Merck says a final decision should come six months after it submits the added data. Report

> Regulators say that MedImmune's inhalable flu vaccine is effective in children under five but may increase the risk of repiratory illness. Report

> Chutes & Ladders: Cell Therapeutics has named a management team for its recently-formed subsidiary Aequus BioPharma. Carl J. March, Ph.D., former senior vice president at Immunex, has been chosen as president and CEO. Release

> The UK's National Institute for Health and Clinical Excellence has once again rejected Erbitux as a therapy for head and neck cancer, saying that it no better or cheaper than existing therapies. Report

> Canada's Biovail has been notified by the SEC that the agency is considering taking action against the company for accounting and disclosure violations. Report

> Validus Pharmaceuticals has acquired Marplan (isocarboxazid) from Oxford Pharmaceuticals. Release

> The FDA has approved a new dosage of Merck's FOSAMAX PLUS D. Release

And Finally…The mammography rate in the U.S. has been steadily declining in recent years. Release

Suggested Articles

The readouts link the oral oxidative phosphorylation blocker imeglimin to near- and long-term improvements when given as a monotherapy and in combos.

Scientists at the University of Toronto, in collaboration with Agios, identified 182 genes that allow cancer cells to evade the immune system.

The FDA’s advisory committee chair has stepped down from reviewing the upcoming pandemic vaccines given her role in Moderna’s COVID-19 test.